[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"gynecologic-surgery\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:gynecologic-surgery":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,43,80,107],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100631908","impact-of-combined-intravenous-inhalational-vs-inhalational-anesthesia-on-qor-15-recovery-scores-in-gynecologic-surgery-100631908",false,"NCT07506798","Impact of Combined Intravenous-Inhalational vs Inhalational Anesthesia on QoR-15 Recovery Scores in Gynecologic Surgery","Effects of Combined Intravenous-Inhalational Anesthesia Versus Inhalational Anesthesia on Postoperative Recovery in Gynecological Operations: A Comparison Based on QoR-15 Scores","Inclusion Criteria:\n\n1. Patients aged 18-65 years\n2. Scheduled for elective gynecologic surgery at Sakarya University Faculty of Medicine Training and Research Hospital\n3. Classified as ASA I-III\n4. Able to understand and complete the QoR-15 questionnaire\n5. Provided written informed consent\n\nExclusion Criteria:\n\n1. Severe comorbidities (beyond ASA III)\n2. Patients with advanced neurological disease or cognitive impairment\n3. Known allergy to anesthetic drugs used in the study\n4. Classified as ASA IV-V\n5. Refusal to participate in the study\n6. Emergency or urgent surgery","ALL","18 Years","65 Years",{"count":20,"type":21},100,"ESTIMATED","INTERVENTIONAL",[24],"NA","This study aims to compare the effects of combined intravenous-inhalational anesthesia versus inhalational anesthesia alone on postoperative recovery in patients undergoing elective gynecologic surgery.\n\nA total of 100 patients, aged 18-65 years and classified as ASA I-III, scheduled for elective gynecologic procedures at Sakarya University Faculty of Medicine Training and Research Hospital, will be included. The sample size was calculated based on the primary outcome, the Quality of Recovery-15 (QoR-15) score.\n\nPatients will complete the QoR-15 questionnaire preoperatively, before knowing which anesthesia method will be applied. Postoperative QoR-15 scores will be collected on postoperative days 1 and 2, and intraoperative data will be obtained from anesthesia records.\n\nThe study evaluates postoperative recovery using QoR-15 scores, covering physical comfort, emotional state, psychological support, pain, and ability to perform daily activities. Higher scores indicate better recovery, whereas lower scores indicate impaired postoperative recovery.",[27,28,29],"Gynecologic Surgery","Postoperative Recovery","Anesthesia","RECRUITING","2026-03-28",{"date":33,"type":34},"2026-04-02","ACTUAL",{"date":36,"type":34},"2025-10-01",{"date":38,"type":21},"2027-04",{"name":40,"class":41},"Sakarya University","OTHER",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":11,"sex":51,"minAge":4,"maxAge":18,"enrollmentInfo":52,"targetDuration":4,"studyType":22,"phases":54,"briefSummary":55,"conditions":56,"keywords":59,"overallStatus":69,"whyStopped":4,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":79},"100612247","hemodynamic-effects-of-remimazolam-vs-propofol-during-robot-assisted-gynecologic-surgery-100612247","NCT07251101","Hemodynamic Effects of Remimazolam vs Propofol During Robot-assisted Gynecologic Surgery","A Randomized, Parallel, Open-label With Blinded Assessment Study Comparing Hemodynamic Profiles Between Remimazolam- and Propofol-based Total Intravenous Anesthesia in Patients Undergoing Robot-assisted Gynecologic Surgery","By_HD","Inclusion Criteria:\n\n* Female patients \\\u003C65 years of age\n* American Society of Anesthesiologists (ASA) physical status I-II\n* Scheduled to undergo robotic hysterectomy under general anesthesia\n\nExclusion Criteria:\n\n* Body mass index (BMI) \\> 35 kg\u002Fm²\n* Baseline hypotension (systolic blood pressure \\\u003C100 mmHg) or bradycardia (heart rate \\\u003C60 bpm)\n* History of ischemic heart disease or cardiac conduction block\n* Significant cardiopulmonary disease, including hypoxemia (SpO₂ \\\u003C90%), uncontrolled asthma, or chronic obstructive pulmonary disease (COPD)\n* Use of inhalational anesthetics during anesthesia\n* Conversion from robotic\u002Flaparoscopic surgery to open laparotomy","FEMALE",{"count":53,"type":21},58,[24],"This single-center study at CHA Ilsan Medical Center compares intraoperative hemodynamics between remimazolam- and propofol-based total intravenous anesthesia (TIVA) in patients undergoing robot-assisted gynecologic surgery requiring pneumoperitoneum and steep Trendelenburg positioning.",[57,58,27],"Anesthesia, Intravenous","Hemodynamic Stability",[60,61,62,63,64,65,66,67,68],"remimazolam","propofol","hemodynamics","laparoscopic surgery","general anesthesia","Trendelenburg position","pneumoperitoneum","gynecologic surgery","total intravenous anesthesia (TIVA)","NOT_YET_RECRUITING","2026-03-23",{"date":72,"type":34},"2026-03-27",{"date":74,"type":21},"2026-05-02",{"date":76,"type":21},"2027-12-30",{"name":78,"class":41},"Ilsan Cha hospital",2,{"id":81,"slug":82,"hasResults":11,"nctId":83,"briefTitle":84,"officialTitle":85,"acronym":4,"eligibilityCriteria":86,"healthyVolunteers":11,"sex":51,"minAge":87,"maxAge":88,"enrollmentInfo":89,"targetDuration":4,"studyType":22,"phases":91,"briefSummary":92,"conditions":93,"keywords":95,"overallStatus":69,"whyStopped":4,"lastUpdateSubmitDate":98,"lastUpdatePostDateStruct":99,"startDateStruct":101,"completionDateStruct":103,"leadSponsor":105,"locationsCount":42},"100604181","long-term-follow-up-of-bio-signals-and-quality-of-recovery-following-implementation-of-eras-100604181","NCT07146178","Long-term Follow-up of Bio-signals and Quality of Recovery Following Implementation of ERAS","Long-term Follow-up of Bio-signals and Quality of Recovery Following Implementation of Enhanced Recovery After Surgery(ERAS) Program","Inclusion Criteria:\n\n* Age between 20 and 70 years\n* Scheduled to undergo gynecologic laparoscopic surgery under general anesthesia\n* Use of an Android smartphone\n\nExclusion Criteria:\n\n* American Society of Anesthesiologists(ASA) physical status classification IV or higher\n* Body Mass Index (BMI) 35 or higher\n* Presence of diabetic autonomic neuropathy\n* History of esophageal hiatal hernia or delayed stomach discharge\n* Known allergy to local anesthesia\n* Participantion in other trials that may affect study outcomes\n* Inability to complete questionnaires (e.g., due to cognitive impairment)","20 Years","70 Years",{"count":90,"type":21},200,[24],"The goal of this clinical trial is to evaluate the effect of an Enhanced Recovery After Surgery(ERAS) protocol in patients undergoing gynecologic laparoscopic surgery under general anesthesia. The main question it aims to answer is: Does the ERAS protocol improve the quality of recovery compared to standard treatments?\n\nResearchers will compare ERAS protocol with standard treatment to see if ERAS protocol improves the quality of recovery after surgery.\n\nParticipants will:\n\n* Receive ERAS protocol during the hospitalization\n* Undergo bio-signal monitoring for one month using Hi-Cardi Plus device and Galaxy Watch 7\n* Visit the hospital at one week and one month after discharge\n* Complete questionnaires(QOR-15K, WHO-DAS 2.0, EQ-5D-3L) at 24 hours after surgery, at discharge, one week after discharge, and one month after discharge",[27,94],"General Anesthesia",[96,97],"Enhanced recovery after surgery","bio-signal monitoring","2025-08-21",{"date":100,"type":34},"2025-08-28",{"date":102,"type":21},"2025-09-01",{"date":104,"type":21},"2026-10-01",{"name":106,"class":41},"Wonju Severance Christian Hospital",{"id":108,"slug":109,"hasResults":11,"nctId":110,"briefTitle":111,"officialTitle":112,"acronym":4,"eligibilityCriteria":113,"healthyVolunteers":11,"sex":51,"minAge":17,"maxAge":114,"enrollmentInfo":115,"targetDuration":4,"studyType":22,"phases":116,"briefSummary":117,"conditions":118,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":121,"lastUpdatePostDateStruct":122,"startDateStruct":124,"completionDateStruct":126,"leadSponsor":128,"locationsCount":42},"100479711","a-rct-on-the-preventive-effect-of-hfnc-on-postoperative-pulmonary-complications-in-patients-with-gynecologic-neoplasms-100479711","NCT05526534","A RCT on the Preventive Effect of HFNC on Postoperative Pulmonary Complications in Patients With Gynecologic Neoplasms","A Randomized Controlled Trial on the Preventive Effect of Heated Humidified High Flow Nasal Cannula Oxygen Therapy on Postoperative Pulmonary Complications in Patients With Gynecologic Neoplasms","Inclusion Criteria:\n\n* Patients with gynecologic Neoplasms, including benign gynecologic tumors and malignant gynecologic tumors, who are 18 to 90 years old and are scheduled for surgical treatment in our center shall receive plain chest CT scan within 1 week before surgery, and the estimated surgical time shall be ≥2 hours, and at least one of the following conditions shall be met:\n\n  1. Assess respiratory risk in surgical patients in Catalonia (ARRSPC) ≥45 points;\n  2. BMI≥30;\n  3. Moderate to severe asthma;\n  4. Moderate to severe chronic obstructive pulmonary disease (COPD);\n  5. Smoking history ≥20 packs\u002Fyear\n\nExclusion Criteria:\n\n1. Patients with lung metastasis of malignant tumor or primary lung malignant tumor;\n2. previous lung surgery or radiotherapy;\n3. the surgery involved segmental bowel resection.","90 Years",{"count":90,"type":21},[24],"Patients at high risk of post-operative pulmonary complications (PPC) will be screened out from gynecological tumor patients undergoing surgical treatment, and randomly assigned into the HFNC group and control group, which uses conventional nasal cannula oxygen therapy. The primary outcome is the incidence of PPC, including postoperative hypoxemia, atelectasis, pneumonia, etc. Secondary outcomes are the improvement of postoperative oxygenation, antibiotic use, length of hospital stay, adverse events related to oxygen therapy, etc.",[27,119,120],"High-flow Nasal Cannula","Post-operative Pulmonary Complications","2025-05-20",{"date":123,"type":34},"2025-05-23",{"date":125,"type":34},"2022-11-01",{"date":127,"type":21},"2025-12-31",{"name":129,"class":41},"Sichuan Cancer Hospital and Research Institute"]